What’s next after China court freezes US$318m in Nexperia assets amid Wingtech battle?
A Chinese court has frozen 2.14 billion yuan (US$318 million) in assets belonging to Nexperia-affiliated entities in China. The order, issued by the Dongguan Intermediate People’s Court, affects equity interests in four subsidiaries of the Dutch firm and one Chinese entity owned by Itec BV, a chip tool maker spun off from Nexperia. This action is part of a prolonged custody battle and is set to last for three years, until August 2029. The frozen assets are located across Dongguan, Shanghai, and Wuxi, aiming to protect Chinese subsidiaries' assets from being transferred or pledged.
The freezing of Nexperia's 2.14 billion yuan in assets by a Chinese court underscores the increasing isolation of its local manufacturing operations from its European headquarters. This move, stemming from a custody battle, effectively cements the operational independence of Nexperia's Chinese engine. While daily operations are reportedly unaffected, the three-year asset freeze until August 2029 points to a significant challenge for Nexperia's strategic flexibility in China. For the Asian semiconductor market, this development highlights the complexities and risks associated with cross-border ownership and legal disputes in the chip industry. The Dongguan court's decision to protect Chinese subsidiaries' assets reflects a broader trend of national interests influencing corporate control, particularly in critical technology sectors. The thing to watch is how this prolonged legal entanglement impacts Nexperia's ability to invest and innovate within China, and whether it prompts other foreign chipmakers to re-evaluate their ownership structures in the region.
Related reading
6 stories
As Chinese chipmakers snap up local gear, self-sufficiency drive faces commercial test
We previously covered China's drive for chip self-sufficiency, a backdrop to this asset freeze.

Xi touts Brics cooperation on AI as US titans flag tech risks

Shein shares drop to lowest since IPO amid ‘underperform’ rating, contact-lens recall

Thunes Expands Cross Border Payouts Across Six Middle East Markets

DBS TravelLah Debit Card Goes Live With No FX Fees and Separate Travel Wallet

